TY - JOUR
T1 - Recommendations to Improve Quality of Probiotic Systematic Reviews with Meta-Analyses
AU - McFarland, Lynne V.
AU - Hecht, Gail
AU - Sanders, Mary E.
AU - Goff, Debra A.
AU - Goldstein, Ellie J.C.
AU - Hill, Colin
AU - Johnson, Stuart
AU - Kashi, Maryam R.
AU - Kullar, Ravina
AU - Marco, Maria L.
AU - Merenstein, Daniel J.
AU - Millette, Mathieu
AU - Preidis, Geoffrey A.
AU - Quigley, Eamonn M.M.
AU - Reid, Gregor
AU - Salminen, Seppo
AU - Sniffen, Jason C.
AU - Sokol, Harry
AU - Szajewska, Hania
AU - Tancredi, Daniel J.
AU - Woolard, Kristin
N1 - Publisher Copyright:
© 2023 American Medical Association. All rights reserved.
PY - 2023/12/8
Y1 - 2023/12/8
N2 - Importance: Systematic reviews and meta-analyses often report conflicting results when assessing evidence for probiotic efficacy, partially because of the lack of understanding of the unique features of probiotic trials. As a consequence, clinical decisions on the use of probiotics have been confusing. Objective: To provide recommendations to improve the quality and consistency of systematic reviews with meta-analyses on probiotics, so evidence-based clinical decisions can be made with more clarity. Evidence Review: For this consensus statement, an updated literature review was conducted (January 1, 2020, to June 30, 2022) to supplement a previously published 2018 literature search to identify areas where probiotic systematic reviews with meta-analyses might be improved. An expert panel of 21 scientists and physicians with experience on writing and reviewing probiotic reviews and meta-analyses was convened and used a modified Delphi method to develop recommendations for future probiotic reviews. Findings: A total of 206 systematic reviews with meta-analysis components on probiotics were screened and representative examples discussed to determine areas for improvement. The expert panel initially identified 36 items that were inconsistently reported or were considered important to consider in probiotic meta-analyses. Of these, a consensus was reached for 9 recommendations to improve the quality of future probiotic meta-analyses. Conclusions and Relevance: In this study, the expert panel reached a consensus on 9 recommendations that should promote improved reporting of probiotic systematic reviews with meta-analyses and, thereby, assist in clinical decisions regarding the use of probiotics.
AB - Importance: Systematic reviews and meta-analyses often report conflicting results when assessing evidence for probiotic efficacy, partially because of the lack of understanding of the unique features of probiotic trials. As a consequence, clinical decisions on the use of probiotics have been confusing. Objective: To provide recommendations to improve the quality and consistency of systematic reviews with meta-analyses on probiotics, so evidence-based clinical decisions can be made with more clarity. Evidence Review: For this consensus statement, an updated literature review was conducted (January 1, 2020, to June 30, 2022) to supplement a previously published 2018 literature search to identify areas where probiotic systematic reviews with meta-analyses might be improved. An expert panel of 21 scientists and physicians with experience on writing and reviewing probiotic reviews and meta-analyses was convened and used a modified Delphi method to develop recommendations for future probiotic reviews. Findings: A total of 206 systematic reviews with meta-analysis components on probiotics were screened and representative examples discussed to determine areas for improvement. The expert panel initially identified 36 items that were inconsistently reported or were considered important to consider in probiotic meta-analyses. Of these, a consensus was reached for 9 recommendations to improve the quality of future probiotic meta-analyses. Conclusions and Relevance: In this study, the expert panel reached a consensus on 9 recommendations that should promote improved reporting of probiotic systematic reviews with meta-analyses and, thereby, assist in clinical decisions regarding the use of probiotics.
UR - https://www.scopus.com/pages/publications/85179638069
U2 - 10.1001/jamanetworkopen.2023.46872
DO - 10.1001/jamanetworkopen.2023.46872
M3 - Review article
C2 - 38064222
AN - SCOPUS:85179638069
SN - 2574-3805
VL - 6
SP - E2346872
JO - JAMA Network Open
JF - JAMA Network Open
IS - 12
ER -